4//SEC Filing
Brake Rachael Louise 4
Accession 0001209191-23-009635
CIK 0001595097other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 12:56 PM ET
Size
5.5 KB
Accession
0001209191-23-009635
Insider Transaction Report
Form 4
Brake Rachael Louise
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-13+1,400,000→ 1,400,000 totalExercise: $0.14Exp: 2033-02-13→ Common Stock (1,400,000 underlying)
Footnotes (1)
- [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 13 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001898023
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 12:56 PM ET
- Size
- 5.5 KB